Electron paramagnetic resonance (EPR) meets drug delivery and biomaterials: a magnetic love story
Gallez B.
Narrative Review, published in Drug Deliv Transl Res (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Drug Deliv Transl Res (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41094228
- PMCID
- PMC13294175
- DOI
- 10.1007/s13346-025-01992-9
Abstract (original English)
This narrative review underscores the powerful role of Electron Paramagnetic Resonance (EPR), also known as Electron Spin Resonance (ESR), in characterizing drug delivery systems (DDSs). Using drugs or probes tagged with spin labels, EPR provides detailed insights into structural and dynamic properties, as well as the molecular microenvironment (including micro-viscosity, micro-polarity, and micro-pH) and enables real-time monitoring of drug release and degradation processes both in vitro and in vivo. In nanomedicine research, EPR can also serve as a quantitative tool to track the fate of DDSs doped with iron oxide particles that are used in theranostics. Beyond DDS characterization, EPR has contributed substantially to elucidating radical mechanisms within material matrices, notably in bone cements and dental resins used for restorative applications. Moreover, incorporating paramagnetic compounds into DDSs or biomaterials has broadened the scope of EPR applications, enabling precise measurements of oxygen and nitric oxide levels in complex biological environments. The incorporation of oxygen sensors into biocompatible matrices has also enabled the development of implantable resonators for measuring oxygen at substantial tissue depths. Incorporating oxygen sensors into cell therapy implantable devices or grafted tissues can serve as an indicator of both oxygenation and vascular
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.